Clinical Trials on Focal Nodular Hyperplasia

Total 6323 results

Milton S. Hershey Medical Center
Center for Research on Women and Newborn Health

Withdrawn

Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)

Endometrial Hyperplasia
Sanofi

Completed

ALF-ONE : ALFuzosin ONcE Daily

Prostatic Hyperplasia
Sanofi

Completed

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin (SAMBA-Thailand)

Prostatic Hyperplasia

Thailand
Handok Inc.

Completed

Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Prostatic Hyperplasia

Korea, Republic of
Sanofi

Terminated

ALF-STONE: Alfuzosin in Uretheric Stones

Prostatic Hyperplasia

Portugal
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells

Benign Prostatic Hyperplasia | Prostate Carcinoma

United States
HaEmek Medical Center, Israel
Meir Medical Center; Bnai Zion Medical Center; Barzilai Medical Center

Unknown

3D Recording of a Trans-rectal Prostate Biopsy

Benign Prostatic Hyperplasia | Prostate Cancer

Israel
Istanbul University

Completed

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis

Glomerulonephritis | Focal Segmental Glomerulosclerosis

Turkey
Dong-A Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Prostatic Hyperplasia | Prostatitis

Italy
Queen's University

Completed

Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

BPH

Canada
Boston Scientific Corporation

Completed

Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic, Czechia, Sweden
Boston Scientific Corporation

Completed

Rezum FIM Optimization Study (Rezum FIM)

Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic
Duke University
American Academy of Neurology

Recruiting

Accelerated TMS for Focal Hand Dystonia

Isolated Focal Hand Dystonia

United States
National Institute of Neurological Disorders and...

Completed

fMRI Studies of Task Specificity in Focal Hand Dystonia

Focal Dystonia

United States
Royan Institute

Unknown

Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)

Focal Segmental Glomerulosclerosis

Iran, Islamic Republic of
Veracyte, Inc.

Recruiting

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier (NIGHTINGALE)

Lung Cancer | Pulmonary Nodule, Solitary

United States
Seoul National University Hospital

Not yet recruiting

Pulmonary Nodule Cohort (liquidNodule)

Lung Cancer | Pulmonary Nodule, Solitary
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Prostatic Hyperplasia

Brazil
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Prostatic Hyperplasia
Universität des Saarlandes

Completed

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Benign Prostatic Hyperplasia | Primary Prostate Urothelial Cancer

Germany
GlaxoSmithKline

Completed

Korean Practice Patterns for Screening PCA(Prostate Cancer) (RESPECT)

Benign Prostatic Hyperplasia | Prostate Cancer | Neoplasms, Prostate

Korea, Republic of
Krankenhaus Barmherzige Schwestern Linz

Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Endometrial Cancer | Atypical Hyperplasia

Austria
Istanbul University

Completed

Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia

Acute Hyponatremia

Turkey
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Dr Vincent Misrai
Boston Scientific Corporation; Iqvia Pty Ltd

Recruiting

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP)

Benign Prostatic Hyperplasia | Anticoagulant Adverse Reaction

France
University of California, San Diego

Completed

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Prostatic Hyperplasia, Benign | Enlarged Prostate With Lower Urinary Tract Symptoms

United States
Geneplus-Beijing Co. Ltd.
Beijing Hospital; Emergency General Hospital

Recruiting

Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

Pulmonary Nodule, Solitary | Whole-genome Methylation Sequencing

China
University of Chicago

Completed

Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy

Hyperparathyroidism | Thyroid Neoplasms | Goiter, Nodular | Thyroid Nodule | Graves' Disease

United States
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
University of Sao Paulo

Completed

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Glomerulosclerosis, Focal

Brazil
National Institute of Diabetes and Digestive and...

Completed

Evaluation of Albuminuria HIV-Infected Patients

Proteinuria | Albuminuria | HIV-Associated Focal Segmental Glomerulosclerosis | Renal Tubular Toxicity | HIV-Associated Collapsing Glomerulopathy

United States
GlaxoSmithKline

Completed

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Glomerulosclerosis, Focal Segmental

United States, Canada
Can-Am HIFU Inc.

Recruiting

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

Urologic Diseases

Canada
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
ProstaCare Pty Ltd

Not yet recruiting

Neuflo System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
ProArc Medical

Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH (Omega)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Georgia
Société Internationale d'Urologie

Recruiting

BPH Global Registry

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada, Italy, United Kingdom, Cyprus, United States, Chile
ProArc Medical

Recruiting

Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Israel
St. Joseph's Healthcare Hamilton

Not yet recruiting

Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.

Overactive Bladder | Benign Prostatic Hyperplasia

Canada
Fudan University

Completed

Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
João Martins Pisco

Completed

Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Prostatic Diseases | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy, Benign | Genital Diseases, Male

Portugal
Samsung Medical Center

Completed

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Overactive Bladder | Benign Prostatic Hyperplasia

Korea, Republic of
Salzburger Landeskliniken

Unknown

Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate

Benign Prostatic Hyperplasia | Bladder Outlet Obstruction

Austria, Switzerland
West China Second University Hospital

Recruiting

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Atypical Endometrial Hyperplasia | Endometrial Cancer

China
Hopital Foch

Completed

Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level (STERPROSER)

Urinary Bladder Neoplasms | Prostate Hyperplasia

France

Clinical Trials on Focal Nodular Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations